Esketamine for Treatment|Resistant Depression

Esketamine Nasal Spray Effective in Treatment-Resistant Depression

Esketamine nasal spray combined with an oral antidepressant was more effective in treating refractory depression than placebo plus a newly initiated.

TMS and esketamine: high efficacy for patients with treatment ...

About 30-50% of patients with major depression find they do not respond well to various medications. Searching for an effective treatment is a source of ...

Esketamine For Treatment-Resistant Depression | D'Amore

Esketamine is an exciting new treatment for patients with treatment-resistant depression. The opportunity to rapidly relieve symptoms in these difficult cases ...

Esketamine Found to Reduce Postpartum Depression

Recently, esketamine earned FDA approval specifically for use as a nasal spray to treat patients with treatment-resistant depression. A ...

Esketamine's Role in Treating Resistant Depression - YouTube

Explore a significant study on treatment-resistant major depressive disorder in this episode. We examine the potential benefits of ...

Esketamine for Treatment-Resistant Depression | Portsmouth Hospital

Esketamine is widely considered a breakthrough for treatment-resistant depression. About 30 to 40 percent of people with depression do not respond to first-line ...

Esketamine: A New Approach for Patients with Treatment-Resistant ...

For patients with intractable depression, a new esketamine clinic — among the first in the U.S. — can provide immediate relief.

Treatment-Resistant Depression Options | Froedtert & MCW

Esketamine is one of the two molecules in ketamine, a drug widely used in anesthesia. While most antidepressants affect serotonin levels, esketamine is thought ...

Spravato (Esketamine) Nasal Spray First NMDA Receptor ...

This is the first NMDA receptor antagonist to receive FDA approval for treatment-resistant depression, with a new delivery system via a nasal spray.

Efficacy of Esketamine Nasal Spray for TRD in Real-World Clinical ...

The investigators concluded that esketamine nasal spray is associated with significant reductions in depression symptoms for patients with TRD ...

Esketamine for Treatment-Resistant Depression | Regional Hospital

Marketed under the brand name SPRAVATO™, esketamine is a powerful new medication for depression that hasn't responded to at least two other forms of treatment.

How Does SPRAVATO® Work

If you've taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression (TRD).

The Antidepressant That's Saving Lives: Esketamine Nasal Spray

In 2019, esketamine nasal spray (with the brand name “Spravato”) became FDA-approved for treatment-resistant depression in adults. At that time, ...

The use of esketamine in comorbid treatment resistant depression ...

This case report exemplifies possible clinical effects of esketamine on both depressive and OCD symptoms.

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray ...

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, ...

Esketamine | Treatment-Resistant Depression Program

Esketamine (Spravato) Nasal Spray Esketamine is a prescription nasal spray used to help patients with treatment-resistant depression. Esketamine trea...

Esketamine | The Anxiety Center | Cincinnati | Indy

Esketamine, also called Spravato, provides rapid relief for anxiety and depression. Learn more about how we use esketamine at The Anxiety Center.

Esketamine: A Drug to Treat Resistant Depression That...

A novel and rapidly-acting antidepressant, esketamine, was approved by the Food and Drug Administration (FDA) in 2018 for the treatment of depression in adults.

Esketamine Treatment | Institute of Living | Hartford HealthCare | CT

Treatment. Esketamine is a form of Ketamine, a medication used as general anesthesia since the 1960s and more recently used in depression. At the Institute of ...

Esketamine: Uses, Interactions, Mechanism of Action - DrugBank

Esketamine is a NMDA receptor antagonist used for treatment-resistant depression. Brand Names. Spravato. Generic Name: Esketamine; DrugBank Accession Number ...